| abstract |
The present invention provides an indanone derivative and an excellent sigma receptor binding agent containing the indanone derivative. Specifically, the present invention provides a sigma receptor binding agent comprising an indanone derivative represented by the following formula or a pharmacologically acceptable salt thereof or a hydrate thereof. (However, 1-benzyl-4-[(5,6-dimethoxy-1-indanone) -2-yl] methylpiperidine or a pharmaceutically acceptable salt thereof or a hydrate thereof is excluded.) |